/PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is proud to announce that Endosane.
Leading tech vendor sees promising growth for European operators, commits to advancing the industry with an EU-GMP ready eQMS platformOakville, Ontario, April 20, 2023("C15" or the "Company"), a technology
Investegate announcements from C15 Solutions, C15 Solutions Anticipates Substantial Growth in European Cannabis Market Through Innovative Tech Platform
The delegates will witness several panel discussions around compelling global health topics during the event, which is scheduled to happen in Hyderabad on February 24-26, 2023
PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.